Haven’t yet RSVP’d? It’s not too late – click here

As the volume of literature grows exponentially, regular review and synthesis of evidence from diverse sources is crucial for informed decision-making. Choosing the right database can significantly impact the quality and relevance […]

The decision timelines for Nordic HTA agencies vary depending on the agency and submission process. In Sweden, Tandvårds- och läkemedelsförmånsverket, TLV—responsible for the reimbursement system of outpatient medicines —has a maximum processing time of 180 […]

Are you located in Stockholm and working in HEOR, RWE or a similar area in lifescience or biotech? Join us on March 19th at Clarion Hotel® 𝐀𝐦𝐚𝐫𝐚𝐧𝐭𝐞𝐧 for a causual after work mingle with your […]

Together with distinguished speakers from Children’s Hospital of Philadelphia, Brigham and Women’s Hospital, Harvard Medical School, and […]

Since 2020, Quantify Research has been a proud partner to the European Medicines Agency-coordinated ENCePP (European Network for Centers of Pharmacoepidemiology and Pharmacovigilance) initiative.

This network brings together expertise […]

𝐌𝐀𝐒𝐋𝐃/𝐌𝐀𝐒𝐇: 𝐂𝐥𝐢𝐧𝐢𝐜𝐚𝐥 𝐚𝐧𝐝 𝐄𝐜𝐨𝐧𝐨𝐦𝐢𝐜 𝐅𝐢𝐧𝐝𝐢𝐧𝐠𝐬 𝐟𝐫𝐨𝐦 40-𝐲𝐞𝐚𝐫 𝐅𝐨𝐥𝐥𝐨𝐰-𝐔𝐩 𝐃𝐚𝐭𝐚
On Tuesday December 10th, Quantify’s Emilie Toresson Grip is one of three speakers at ISPOR’s webinar on MASLD/ MASH following their BRIDGE-MASH study.

Moderated by Riku Ota, Global Payer Evidence Lead at […]